These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

635 related items for PubMed ID: 16173523

  • 21. Effective immunization against influenza in pediatric renal transplant recipients.
    Edvardsson VO, Flynn JT, Deforest A, Kaiser BA, Schulman SL, Bradley A, Palmer J, Polinsky MS, Baluarte HJ.
    Clin Transplant; 1996 Dec; 10(6 Pt 1):556-60. PubMed ID: 8996778
    [Abstract] [Full Text] [Related]

  • 22. Lack of effect of a booster dose of influenza vaccine in hemodialysis patients.
    Tanzi E, Amendola A, Pariani E, Zappa A, Colzani D, Logias F, Perego A, Zanetti AR.
    J Med Virol; 2007 Aug; 79(8):1176-9. PubMed ID: 17596830
    [Abstract] [Full Text] [Related]

  • 23. Opsonophagocytic activity against Streptococcus pneumoniae type 19F in allogeneic BMT recipients before and after vaccination with pneumococcal polysaccharide vaccine.
    Parkkali T, Väkeväinen M, Käyhty H, Ruutu T, Ruutu P.
    Bone Marrow Transplant; 2001 Jan; 27(2):207-11. PubMed ID: 11281392
    [Abstract] [Full Text] [Related]

  • 24. Specific antibody response after influenza immunization in systemic lupus erythematosus.
    Abu-Shakra M, Press J, Varsano N, Levy V, Mendelson E, Sukenik S, Buskila D.
    J Rheumatol; 2002 Dec; 29(12):2555-7. PubMed ID: 12465151
    [Abstract] [Full Text] [Related]

  • 25. Pneumococcal vaccine in children and young adults with chronic renal disease.
    Fuchshuber A, Kühnemund O, Keuth B, Lütticken R, Michalk D, Querfeld U.
    Nephrol Dial Transplant; 1996 Mar; 11(3):468-73. PubMed ID: 8671817
    [Abstract] [Full Text] [Related]

  • 26. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity.
    Del Porto F, Laganà B, Biselli R, Donatelli I, Campitelli L, Nisini R, Cardelli P, Rossi F, D'Amelio R.
    Vaccine; 2006 Apr 12; 24(16):3217-23. PubMed ID: 16466833
    [Abstract] [Full Text] [Related]

  • 27. Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?
    Beyer WE, Palache AM, Lüchters G, Nauta J, Osterhaus AD.
    Virus Res; 2004 Jul 12; 103(1-2):125-32. PubMed ID: 15163500
    [Abstract] [Full Text] [Related]

  • 28. [Study on the safety and immunogenicity of MF59-adjuvanted influenza subunit vaccine in Chinese elderly].
    Li RC, Fang HH, Li YP, Liu YP, Nong Y, Huang GB.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun 12; 29(6):548-51. PubMed ID: 19040034
    [Abstract] [Full Text] [Related]

  • 29. [Evaluation of an anti-influenza vaccine in a group of elderly].
    Pérez Rodríguez AE, González Ochoa E, de Armas Pérez L, Goyenechea Hernández A.
    Rev Cubana Med Trop; 1990 Jun 12; 42(1):90-100. PubMed ID: 2259788
    [Abstract] [Full Text] [Related]

  • 30. Immunological responses to pneumococcal vaccine in frail older people.
    Ridda I, Macintyre CR, Lindley R, Gao Z, Sullivan JS, Yuan FF, McIntyre PB.
    Vaccine; 2009 Mar 04; 27(10):1628-36. PubMed ID: 19100304
    [Abstract] [Full Text] [Related]

  • 31. Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma.
    Robertson JD, Nagesh K, Jowitt SN, Dougal M, Anderson H, Mutton K, Zambon M, Scarffe JH.
    Br J Cancer; 2000 Apr 04; 82(7):1261-5. PubMed ID: 10755398
    [Abstract] [Full Text] [Related]

  • 32. Vaccination-induced HI antibody response to intraepidemic influenza A(H3N2) virus variants of the 1996-1997 epidemic season.
    Pyhälä R, Ikonen N, Santanen R, Haanpää M, Visakorpi R, Jäppinen P, Valle M.
    J Med Virol; 2001 Nov 04; 65(3):584-9. PubMed ID: 11596097
    [Abstract] [Full Text] [Related]

  • 33. Is there a benefit from an early booster vaccination in the control of equine influenza?
    Heldens JG, van Loon AA, van de Zande S.
    Vet J; 2007 Nov 04; 174(3):592-8. PubMed ID: 17560150
    [Abstract] [Full Text] [Related]

  • 34. Immunogenicity of simultaneous versus sequential administration of a 23-valent pneumococcal polysaccharide vaccine and a quadrivalent influenza vaccine in older individuals: A randomized, open-label, non-inferiority trial.
    Nakashima K, Aoshima M, Ohfuji S, Yamawaki S, Nemoto M, Hasegawa S, Noma S, Misawa M, Hosokawa N, Yaegashi M, Otsuka Y.
    Hum Vaccin Immunother; 2018 Nov 04; 14(8):1923-1930. PubMed ID: 29561248
    [Abstract] [Full Text] [Related]

  • 35. [Safety and immunogenicity of split vaccines of influenza viruses].
    Zhu CL, Fang HH, Zhu FC, Wang YQ, Wu XL, Xue FB, Shen YJ, Lian JZ.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep 04; 18(3):207-9. PubMed ID: 15640848
    [Abstract] [Full Text] [Related]

  • 36. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.
    Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M.
    Arthritis Rheum; 2009 Aug 04; 60(8):2438-47. PubMed ID: 19644961
    [Abstract] [Full Text] [Related]

  • 37. An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine.
    Del Giudice G, Hilbert AK, Bugarini R, Minutello A, Popova O, Toneatto D, Schoendorf I, Borkowski A, Rappuoli R, Podda A.
    Vaccine; 2006 Apr 12; 24(16):3063-5. PubMed ID: 16464520
    [Abstract] [Full Text] [Related]

  • 38. Influenza and pneumococcal vaccination in older veterans: results from the behavioral risk factor surveillance system.
    Chi RC, Reiber GE, Neuzil KM.
    J Am Geriatr Soc; 2006 Feb 12; 54(2):217-23. PubMed ID: 16460371
    [Abstract] [Full Text] [Related]

  • 39. Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.
    Nordøy T, Husebekk A, Aaberge IS, Jenum PA, Samdal HH, Flugsrud LB, Kristoffersen AC, Holte H, Kvaløy S, Kolstad A.
    Bone Marrow Transplant; 2001 Oct 12; 28(7):681-7. PubMed ID: 11704791
    [Abstract] [Full Text] [Related]

  • 40. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease.
    Holvast A, Huckriede A, Wilschut J, Horst G, De Vries JJ, Benne CA, Kallenberg CG, Bijl M.
    Ann Rheum Dis; 2006 Jul 12; 65(7):913-8. PubMed ID: 16322083
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.